Keele, United Kingdom

Phillip Anthony Laycock

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Cheshire, GB (2014)
  • Keele, GB (2019 - 2020)

Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Phillip Anthony Laycock

Introduction

Phillip Anthony Laycock is a notable inventor based in Keele, GB. He has made significant contributions to the field of biomedical engineering, particularly in the development of implantable pharmaceutical compositions and devices for bone treatment. With a total of four patents to his name, Laycock's work is recognized for its innovative approach to addressing medical challenges.

Latest Patents

Laycock's latest patents include an implantable pharmaceutical composition prepared from components consisting of calcium sulfate alpha-hemihydrate, vancomycin, and gentamicin. This composition is designed for the treatment of infections in bone and soft tissue. Another significant patent is a device that fills a bone void while minimizing pressurization, which is crucial for ensuring patient safety during implantation procedures.

Career Highlights

Throughout his career, Laycock has demonstrated a commitment to advancing medical technology. His work at Biocomposites Limited has allowed him to collaborate with other experts in the field and contribute to innovative solutions for bone-related medical issues. His patents reflect a deep understanding of both materials science and pharmacology.

Collaborations

Laycock has worked alongside notable colleagues such as John Joseph Cooper and John Warren Colclough. These collaborations have further enriched his research and development efforts, leading to impactful innovations in the medical field.

Conclusion

Phillip Anthony Laycock's contributions to biomedical engineering through his patents and collaborative efforts highlight his role as a key innovator in the industry. His work continues to influence the development of effective treatments for bone and soft tissue infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…